431 related articles for article (PubMed ID: 27650872)
21. Humoral immune response to oral rabies vaccination in raccoon kits: problems and implications.
Fry TL; Vandalen KK; Shriner SA; Moore SM; Hanlon CA; Vercauteren KC
Vaccine; 2013 Jun; 31(26):2811-5. PubMed ID: 23602534
[TBL] [Abstract][Full Text] [Related]
22. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
Lodmell DL; Esposito JJ; Ewalt LC
Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
[TBL] [Abstract][Full Text] [Related]
23. Vaccination of Egyptian fruit bats (Rousettus aegyptiacus) with monovalent inactivated rabies vaccine.
Peters C; Isaza R; Heard DJ; Davis RD; Moore SM; Briggs DJ
J Zoo Wildl Med; 2004 Mar; 35(1):55-9. PubMed ID: 15193074
[TBL] [Abstract][Full Text] [Related]
24. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X
Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572
[TBL] [Abstract][Full Text] [Related]
25. Poxviral promoters for improving the immunogenicity of MVA delivered vaccines.
Alharbi NK
Hum Vaccin Immunother; 2019; 15(1):203-209. PubMed ID: 30148692
[TBL] [Abstract][Full Text] [Related]
26. Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge.
Kingstad-Bakke B; Kamlangdee A; Osorio JE
Vaccine; 2015 Sep; 33(39):5155-62. PubMed ID: 26271828
[TBL] [Abstract][Full Text] [Related]
27. A recombinant rabies vaccine that prevents viral shedding in rabid common vampire bats (Desmodus rotundus).
Cárdenas-Canales EM; Velasco-Villa A; Ellison JA; Satheshkumar PS; Osorio JE; Rocke TE
PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010699. PubMed ID: 36026522
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of ORFV-based vectors expressing the rabies virus glycoprotein in livestock species.
Martins M; Joshi LR; Rodrigues FS; Anziliero D; Frandoloso R; Kutish GF; Rock DL; Weiblen R; Flores EF; Diel DG
Virology; 2017 Nov; 511():229-239. PubMed ID: 28898730
[TBL] [Abstract][Full Text] [Related]
29. Impact of Molecular Modifications on the Immunogenicity and Efficacy of Recombinant Raccoon Poxvirus-Vectored Rabies Vaccine Candidates in Mice.
Malavé CM; Lopera-Madrid J; Medina-Magües LG; Rocke TE; Osorio JE
Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960182
[TBL] [Abstract][Full Text] [Related]
30. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
[TBL] [Abstract][Full Text] [Related]
31. [Oral vaccination in the control of feral rabies].
Biocca E; Bellani L
Parassitologia; 1988; 30(1):3-12. PubMed ID: 3268770
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Immunogenicity and Efficacy of the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Foxes.
Freuling CM; Kamp VT; Klein A; Günther M; Zaeck L; Potratz M; Eggerbauer E; Bobe K; Kaiser C; Kretzschmar A; Ortmann S; Schuster P; Vos A; Finke S; Müller T
Viruses; 2019 Aug; 11(9):. PubMed ID: 31461981
[No Abstract] [Full Text] [Related]
33. Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine.
Hu L; Ngichabe C; Trimarchi CV; Esposito JJ; Scott FW
Vaccine; 1997; 15(12-13):1466-72. PubMed ID: 9302762
[TBL] [Abstract][Full Text] [Related]
34. Feline herpesvirus vectored-rabies vaccine in cats: A dual protection.
Chen T; Zhou X; Qi Y; Mi L; Sun X; Zhang S; Liu Y; Olson V; Qiu W; Wu X; Hu R
Vaccine; 2019 Apr; 37(16):2224-2231. PubMed ID: 30878247
[TBL] [Abstract][Full Text] [Related]
35. Experimental infection of Artibeus intermedius with a vampire bat rabies virus.
Obregón-Morales C; Aguilar-Setién Á; Perea Martínez L; Galvez-Romero G; Martínez-Martínez FO; Aréchiga-Ceballos N
Comp Immunol Microbiol Infect Dis; 2017 Jun; 52():43-47. PubMed ID: 28673461
[TBL] [Abstract][Full Text] [Related]
36. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R
Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474
[TBL] [Abstract][Full Text] [Related]
37. ONRAB® oral rabies vaccine is shed from, but does not persist in, captive mammals.
Sobey KG; Jamieson SE; Walpole AA; Rosatte RC; Donovan D; Fehlner-Gardiner C; Nadin-Davis SA; Davies JC; Kyle CJ
Vaccine; 2019 Jul; 37(31):4310-4317. PubMed ID: 31248686
[TBL] [Abstract][Full Text] [Related]
38. Comparison of antibody response to a non-adjuvanted, live canarypox-vectored recombinant rabies vaccine and a killed, adjuvanted rabies vaccine in Eld's deer (Rucervus eldi thamin).
Marrow JC; Padilla LR; Hayek LA; Bush M; Murray S
J Zoo Wildl Med; 2014 Jun; 45(2):315-20. PubMed ID: 25000692
[TBL] [Abstract][Full Text] [Related]
39. Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection.
Lodmell DL; Sumner JW; Esposito JJ; Bellini WJ; Ewalt LC
J Virol; 1991 Jun; 65(6):3400-5. PubMed ID: 2033678
[TBL] [Abstract][Full Text] [Related]
40. Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus.
Shipley R; Wright E; Lean FZX; Selden D; Horton DL; Fooks AR; Banyard AC
Viruses; 2021 May; 13(5):. PubMed ID: 34065574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
